1. Home
  2. ALTR vs EXAS Comparison

ALTR vs EXAS Comparison

Compare ALTR & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALTR
  • EXAS
  • Stock Information
  • Founded
  • ALTR 1985
  • EXAS 1995
  • Country
  • ALTR United States
  • EXAS United States
  • Employees
  • ALTR N/A
  • EXAS N/A
  • Industry
  • ALTR Computer Software: Prepackaged Software
  • EXAS Medical Specialities
  • Sector
  • ALTR Technology
  • EXAS Health Care
  • Exchange
  • ALTR Nasdaq
  • EXAS Nasdaq
  • Market Cap
  • ALTR 9.6B
  • EXAS 8.8B
  • IPO Year
  • ALTR 2017
  • EXAS N/A
  • Fundamental
  • Price
  • ALTR N/A
  • EXAS $43.66
  • Analyst Decision
  • ALTR Hold
  • EXAS Strong Buy
  • Analyst Count
  • ALTR 7
  • EXAS 18
  • Target Price
  • ALTR $101.00
  • EXAS $70.59
  • AVG Volume (30 Days)
  • ALTR 792.1K
  • EXAS 2.0M
  • Earning Date
  • ALTR 05-01-2025
  • EXAS 05-07-2025
  • Dividend Yield
  • ALTR N/A
  • EXAS N/A
  • EPS Growth
  • ALTR N/A
  • EXAS N/A
  • EPS
  • ALTR 0.16
  • EXAS N/A
  • Revenue
  • ALTR $665,788,000.00
  • EXAS $2,758,867,000.00
  • Revenue This Year
  • ALTR $9.64
  • EXAS $13.02
  • Revenue Next Year
  • ALTR $7.30
  • EXAS $13.02
  • P/E Ratio
  • ALTR $676.98
  • EXAS N/A
  • Revenue Growth
  • ALTR 8.66
  • EXAS 10.37
  • 52 Week Low
  • ALTR $75.71
  • EXAS $40.62
  • 52 Week High
  • ALTR $113.12
  • EXAS $79.62
  • Technical
  • Relative Strength Index (RSI)
  • ALTR 0.98
  • EXAS 38.22
  • Support Level
  • ALTR $111.33
  • EXAS $44.00
  • Resistance Level
  • ALTR $112.31
  • EXAS $47.23
  • Average True Range (ATR)
  • ALTR 0.31
  • EXAS 1.64
  • MACD
  • ALTR -7.13
  • EXAS 0.17
  • Stochastic Oscillator
  • ALTR 0.00
  • EXAS 30.95

About ALTR Altair Engineering Inc.

Altair Engineering Inc is a provider of enterprise-class engineering software enabling origination of the entire product lifecycle from concept design to in-service operation. The integrated suite of software provided by the company optimizes design performance across multiple disciplines encompassing structures, motion, fluids, thermal management, system modeling, and embedded systems. It operates through two segments: Software which includes the portfolio of software products such as solvers and optimization technology products, modeling and visualization tools, industrial and concept design tools, and others; and Client Engineering Services which provides client engineering services to support customers. Majority of its revenue comes from the software segment.

About EXAS Exact Sciences Corporation

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.

Share on Social Networks: